Lung colonization and metastasis by disseminated b16 melanoma cells: H‐2 associated control at the level of the host and the tumor cell
暂无分享,去创建一个
[1] V. Miller,et al. Suppression of NK-mediated natural resistance by interferon treatment of murine lymphomas. , 1984, Journal of immunology.
[2] S. Segal,et al. Immuno‐selection In vivo of H‐2D phenotypic variants from a metastatic clone of sarcoma cells results in cell lines of altered metastatic competence , 1984, International journal of cancer.
[3] E. Gorelik,et al. Role of nk cells in the antimetastatic effect of anticoagulant drugs , 1984, International journal of cancer.
[4] P. Lollini,et al. IMPAIRED H‐2 EXPRESSION IN B 16 MELANOMA VARIANTS , 1983, Journal of immunogenetics.
[5] P. Beverley,et al. Interferon, β-2-microglobulin and immunoselection in the pathway to malignancy A blinkered view from Nag's Head Yard. , 1983, Immunology today.
[6] P. De Baetselier,et al. Alterations in major histocompatibility complex phenotypes of mouse cloned T10 sarcoma cells: association with shifts from nonmetastatic to metastatic cells. , 1983, Journal of the National Cancer Institute.
[7] S. Segal,et al. MHC imbalance and metastatic spread in Lewis lung carcinoma clones , 1983, International journal of cancer.
[8] S. Ferrone,et al. Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions. , 1983, Journal of immunology.
[9] G. Klein,et al. Thymus independence of hybrid resistance against a panel of T‐cell lymphomas of H‐2b origin , 1982, International journal of cancer.
[10] R. Burton,et al. Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo. , 1981, Journal of immunology.
[11] N. Tamaoki,et al. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. , 1981, Journal of immunology.
[12] S. Segal,et al. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice. , 1981, Journal of the National Cancer Institute.
[13] K. Ozato,et al. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. , 1981, Journal of immunology.
[14] R. Welsh,et al. Interferon-mediated protection of normal and tumor target cells against lysis by mouse natural killer cells. , 1981, Journal of immunology.
[15] S. Segal,et al. Differential expression of H–2 gene products in tumour cells is associated with their metastatogenic properties , 1980, Nature.
[16] G. Carlson,et al. H‐2 associated resistance to leukaemia transplantation: Natural killing in vivo , 1980, International journal of cancer.
[17] I. Fidler,et al. The pathogenesis of cancer metastasis , 1980, Nature.
[18] C. Riccardi,et al. Rapid in vivo assay of mouse natural killer cell activity. , 1979, Journal of the National Cancer Institute.
[19] William E. Stewart,et al. The Interferon System , 1979, Springer Vienna.
[20] M. Edidin,et al. Effect of the H-2 gene complex rates of fibroblast intercellular adhesion , 1978, The Journal of cell biology.
[21] E. Clark,et al. Resistance of H-2 heterozygous mice to parental tumors. II. Characterization of Hh-1 controlled hybrid resistance to syngeneic fibrosarcomas and the EL-4 lymphoma. , 1977, Journal of immunology.
[22] I. Fidler,et al. Relationship of host immune status to tumor cell arrest, distribution, and survival in experimental metastasis , 1977, Cancer.
[23] I. Hilgert,et al. Search for the physiological function of H‐2 gene products , 1977, European journal of immunology.
[24] I. Gresser,et al. Differential effects of interferon on the expression of H-2K, H-2D, and Ia antigens on mouse lymphocytes. , 1977, Journal of immunology.
[25] G. Klein,et al. Non‐T‐cell resistance against a mouse moloney lymphoma , 1976, International journal of cancer.
[26] M. Bennett,et al. PECULIAR IMMUNOBIOLOGY OF BONE MARROW ALLOGRAFTS , 1971, Journal of Experimental Medicine.
[27] F. Burnet,et al. “Self-recognition” in Colonial Marine Forms and Flowering Plants in relation to the Evolution of Immunity , 1971, Nature.
[28] C. Mckhann,et al. ANTIGENIC SPECIFICITIES ON MURINE SARCOMA CELLS , 1971, The Journal of experimental medicine.
[29] K. Kärre. ROLE OF TARGET HISTOCOMPATIBILITY ANTIGENS IN REGULATION OF NATURAL KILLER ACTIVITY: A REEVALUATION AND A HYPOTHESIS1 , 1985 .
[30] P. Doherty,et al. Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function. , 1984, Advances in cancer research.
[31] K. Kärre,et al. THE BEIGE MODEL IN STUDIES OF NATURAL RESISTANCE TO SYNGENEIC, SEMISYNGENEIC, AND PRIMARY TUMORS , 1982 .